low-molecular weight heparin
Showing 1 - 25 of >10,000
Venous Thromboembolism Trial in Toronto (Prophylactic low molecular weight heparin, Low molecular weight heparin and low-dose
Recruiting
- Venous Thromboembolism
- Prophylactic low molecular weight heparin
- Low molecular weight heparin and low-dose aspirin
-
Toronto, Ontario, CanadaMount Sinai Hospital
Jan 18, 2023
BMD and Ca-P Metabolism in RSA Patients: LMWH Use Versus Control
Recruiting
- Recurrent Spontaneous Abortion
- Low molecular weight heparin
-
Shanghai, Shanghai, ChinaRenji Hospital, Shanghai Jiaotong University School of Medicine
May 18, 2023
Compare Health Care Costs Between Apixaban and Low Molecular
Active, not recruiting
- Thromboembolism
-
New York, New YorkPfizer Investigational
Dec 1, 2022
Sarcoma, Soft Tissue Sarcoma, Bone Sarcoma Trial in Boston (Aspirin 325mg, Enoxaparin 40Mg/0.4mL Prefilled Syringe)
Enrolling by invitation
- Sarcoma
- +6 more
- Aspirin 325mg
- Enoxaparin 40Mg/0.4mL Prefilled Syringe
-
Boston, MassachusettsSantiago Lozano-Calderon
Jan 20, 2023
Stroke Trial in Kastamonu (The Effect of Different Pressure Periods on Bruising and Pain After Subcutaneous Heparin Injection
Completed
- Stroke
- The Effect of Different Pressure Periods on Bruising and Pain After Subcutaneous Heparin Injection Applied to the Upper Arm Region
-
Kastamonu, TurkeyKastamonu University
Oct 6, 2023
Dose Regimen of Intravenous Unfractionated Heparin and Low
Active, not recruiting
- COVID-19
- +3 more
-
Gent, BelgiumGhent University Hospital
Oct 24, 2022
Injection Site Bruising, Bruising, Pain Trial (Cold application)
Completed
- Injection Site Bruising
- +2 more
- Cold application
- (no location specified)
Mar 4, 2023
Venous Thromboembolism Trial (Peak value anti-Xa, Trough value anti-Xa, Control Group)
Not yet recruiting
- Venous Thromboembolism
- Peak value anti-Xa
- +2 more
- (no location specified)
May 15, 2022
Sterility Trial in Beirut (Bemiparin sodium)
Recruiting
- Sterility
- Bemiparin sodium
-
Beirut, LebanonAmerican University of Beirut Medical Center
Feb 21, 2022
Atrial Fibrillation in Patients With Cancer (MAFIC Study)
Recruiting
- Cancer
- Atrial Fibrillation
- Low molecular weight heparin
-
Thessaloniki, Greece
- +1 more
Feb 14, 2022
Rivaroxaban Versus Low-molecular-weight Heparin and
Completed
- Venous Thromboembolism
- Rivaroxaban (Xarelto, BAY 59-7939)
- LMWH and Phenprocoumon
-
Multiple Locations, GermanyMultiple facilities
Apr 27, 2022
Is Anti-Factor Xa Associated With Outcome in Critical COVID-19
Completed
- Covid19
- +2 more
- The effect of LMWH
- Monitoring frequency of aFXa-levels
-
Stockholm, SwedenSödersjukhuset
Feb 24, 2022
Venous Thromboembolism Trial in Moscow (drug, device, diagnostic test)
Recruiting
- Venous Thromboembolism
- Standard Enoxaparin 40 mg once-daily before randomization
- +4 more
-
Moscow, Russian FederationMoscow Clinical Hospital no.24
Feb 14, 2022
Reduced Dose Thrombolytic in Intermediate/High Risk Pulmonary
Recruiting
- Pulmonary Embolism
- Tissue Plasminogen Activator, Alteplase
- Low-molecular weight heparin
-
İzmir, Bornova/İzmir, TurkeyEge University
Aug 22, 2022
COVID-19 Acute Respiratory Distress Syndrome, Hypoxemia Trial in Istanbul (Inhaled Low molecular weight heparin, Standard
Completed
- COVID-19 Acute Respiratory Distress Syndrome
- Hypoxemia
- Inhaled Low molecular weight heparin
- Standard Treatment
-
Istanbul, Fatih, TurkeyIstanbul University Medical Faculty
Aug 3, 2021
Arterial Occlusion Trial in Thessaloníki (low molecular weight heparin)
Completed
- Arterial Occlusion
- low molecular weight heparin
-
Thessaloníki, Greece1st Cardiology Department, University General Hospital AHEPA
Jul 28, 2021
The Clinical Features and Pregnancy Outcomes of CTD Patients
Recruiting
- Connective Tissue Diseases
- Pregnancy Related
- Prednisone
- +3 more
-
Jinan, Shandong, ChinaQilu Hospital
Sep 26, 2022
Venous Thromboembolism, Pulmonary Embolism Trial in Baltimore (VTE prophylaxis with Enoxaparin 30mg BID, VTE prophylaxis with
Completed
- Venous Thromboembolism
- Pulmonary Embolism
- VTE prophylaxis with Enoxaparin 30mg BID
- VTE prophylaxis with Aspirin 81mg BID
-
Baltimore, MarylandUniversity of Maryland Medical Center
Jan 3, 2022
Critical Illness Trial (Nadroparin (intravenous Infusion), Nadroparin (subcutaneous group))
Completed
- Critical Illness
- Nadroparin (intravenous Infusion)
- Nadroparin (subcutaneous group)
- (no location specified)
Jul 19, 2021
Gather Information About Rivaroxaban in Sweden With Cancer Who
Active, not recruiting
- Treatment of Venous Thromboembolism in Cancer Patients
- Rivaroxaban (Xarelto, BAY59-7939)
- +3 more
-
Multiple Locations, Many Locations, SwedenSwedish registries
Aug 18, 2022
Covid19 Trial in Germany (Anticoagulation Agents (Edoxaban and/or high dose LMWH), Low dose Low molecular weight heparin or
Recruiting
- Covid19
- Anticoagulation Agents (Edoxaban and/or high dose LMWH)
- Low dose Low molecular weight heparin or Placebo
-
Aachen, Germany
- +9 more
May 16, 2022
After Tissue Glue for Gastric Varices
Recruiting
- Anticoagulants and Bleeding Disorders
- +2 more
- Low molecular weight heparin
-
Jinan, Shandong, ChinaDepartment of Gastroenterology,Qilu Hospital,Shandong University
Sep 15, 2022